Regeneron Phar. receives Investment Bank Analyst Rating Update
- ByInvesting.com-
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Regeneron Pharmaceuticals Inc (REGN)
613.61
-1.35(-0.22%)
After Hours
612.51
-1.10(-0.18%)
- Real-time Data
- Volume:566,479
- Day's Range:606.96 - 621.63
- 52 wk Range:538.01 - 747.42
REGN Overview
- Prev. Close
- 614.96
- Day's Range
- 606.96-621.63
- Revenue
- 14.23B
- Open
- 613.47
- 52 wk Range
- 538.01-747.42
- EPS
- 53.27
- Volume
- 566,479
- Market Cap
- 65.6B
- Dividend (Yield)
- N/A(N/A)
- Average Volume (3m)
- 669,118
- P/E Ratio
- -
- Beta
- 0.284
- 1-Year Change
- 0.45%
- Shares Outstanding
- 106,908,322
- Next Earnings Date
- 07 Nov 2022
What is your sentiment on Regeneron Pharma?
or
Market is currently closed. Voting is open during market hours.
Regeneron Pharmaceuticals Inc Analysis
- July’s Big Rally Could Continue, But Consider The Risks
Stocks surged in July, with the major indexes enjoying their best gains since 2020. But the market is still off substantially for the year. The rally came despite the Federal...
- Looking To Diversify Your Portfolio? Here Are 2 Actively Managed ETFs To Consider
Since January, over 100 new actively managed funds have started tradingAs markets slide, actively managed funds become more appealingNote that actively managed funds tend to have...
- Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Regeneron Pharmaceuticals Inc Company Profile
Regeneron Pharmaceuticals Inc Company Profile
Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Sell | Neutral | Strong Buy | Buy |
| Summary | Strong Buy | Neutral | Neutral | Strong Buy | Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.005 | 7.02 | 6.92 | +0.055 | +0.79% | 3.47M | Sydney | |||
| 6.38 | 6.66 | 6.35 | -0.28 | -4.13% | 74.27K | Sydney | |||
| 39.05 | 39.10 | 38.63 | +0.240 | +0.62% | 4.27M | Sydney | |||
| 224.00 | 225.32 | 220.87 | +0.15 | +0.07% | 63.25K | Sydney | |||
| 3.20 | 3.23 | 3.15 | +0.03 | +0.95% | 563.51K | Sydney | |||
| 8.46 | 8.48 | 7.76 | +0.500 | +6.28% | 528.29K | Sydney | |||
| 102.49 | 102.68 | 101.03 | +1.080 | +1.06% | 729.09K | Sydney | |||
| 12.20 | 12.27 | 11.98 | -0.26 | -2.13% | 338.33K | Sydney | |||
| 16.71 | 16.75 | 16.36 | +0.170 | +1.03% | 420.11K | Sydney | |||
| 20.24 | 20.69 | 20.13 | -0.590 | -2.83% | 1.06M | Sydney | |||
| 18.90 | 19.02 | 18.34 | +0.760 | +4.19% | 4.75M | Sydney | |||
| 3.925 | 3.95 | 3.87 | +0.095 | +2.48% | 7.84M | Sydney | |||
| 1.16 | 1.168 | 1.145 | -0.005 | -0.43% | 3.32M | Sydney | |||
| 17.68 | 17.75 | 17.41 | -0.17 | -0.95% | 467.23K | Sydney | |||
| 1.40 | 1.405 | 1.365 | +0.005 | +0.36% | 1.40M | Sydney |